China Joe’s Priorities: Repeal Trump’s Drug Rebate Rule for America’s Seniors, But Spend Billions on China’s EVs
This is yet another instance where Democrats will sacrifice the needs of vulnerable Americans on the altar of their Green God.
![alg-spc-6-26-24](https://media.breitbart.com/media/2024/06/alg-spc-6-26-24-420x315.png)
This is yet another instance where Democrats will sacrifice the needs of vulnerable Americans on the altar of their Green God.
This is yet another instance where Democrats will sacrifice the needs of vulnerable Americans on the altar of their Green God.
Joe Biden’s disastrous Inflation Reduction Act hasn’t just sabotaged Americans’ wallets, it’s sabotaged their health as well.
Joe Biden is giving billions to China’s economy, while cutting Medicare for seniors and killing American jobs.
“I’m going to continue to work to bust this up,” Rep. Buddy Carter (R-GA) told UnitedHealth Group CEO Andrew Witty at a Wednesday hearing on Capitol Hill.
It seems like when Obama said: “If you like your plan, you can keep it,” “This won’t cover illegal aliens,” “This won’t add a dime to the deficit,” or even “Obama cares,” what he meant was: “We will make your healthcare a badly run vertically integrated monopoly that will withhold care, enrich executives, and expose you to hackers.”
It seems like when Obama said: “If you like your plan, you can keep it,” “This won’t cover illegal aliens,” “This won’t add a dime to the deficit,” or even “Obama cares,” what he meant was: “We will make your healthcare a badly run vertically integrated monopoly that will withhold care, enrich executives, and expose you to hackers.”
In addition to destroying normal people’s ability to pay for oil, housing, and food, now Democrats have their sights set on medicine.
Insurance companies and their “pharmacy benefit managers” have gamed the system, and their profits are up tens of billions.
The following article is sponsored by Americans for Limited Government and authored by Richard Manning.
Saddling the world’s most important drug market with price controls would be nothing short of devastating to medical innovation.
Foreign countries with socialized medicine should not be used to determine U.S. drug prices.